Your browser doesn't support javascript.
loading
CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study.
Costiniuk, Cecilia T; Singer, Joel; Langlois, Marc-André; Kulic, Iva; Needham, Judy; Burchell, Ann; Jenabian, Mohammad-Ali; Walmsley, Sharon; Ostrowski, Mario; Kovacs, Colin; Tan, Darrell; Harris, Marianne; Hull, Mark; Brumme, Zabrina; Brockman, Mark; Margolese, Shari; Mandarino, Enrico; Angel, Jonathan B; Routy, Jean-Pierre; Anis, Aslam H; Cooper, Curtis.
Affiliation
  • Costiniuk CT; Department of Medicine, Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Centre, Department of Microbiology and Immunology, McGill Universi
  • Singer J; Canadian Institutes of Health Research (CIHR)--Canadian HIV Trials Network and Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Langlois MA; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Kulic I; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
  • Needham J; Canadian Institutes of Health Research (CIHR)--Canadian HIV Trials Network and Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Burchell A; Canadian Institutes of Health Research (CIHR)--Canadian HIV Trials Network and Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, British Columbia, Canada.
  • Jenabian MA; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Walmsley S; Department of Family and Community Medicine, St Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Ontario, Canada.
  • Ostrowski M; Department of Biological Sciences and CERMO-FC Research Centre, Université du Québec à Montréal (UQAM), Montreal, Quebec, Canada.
  • Kovacs C; Department of Medicine, Division of Infectious Diseases, Toronto General Hospital, Toronto, Ontario, Canada.
  • Tan D; Clinical Sciences Division and Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Harris M; Department of Medicine, Division of Infectious Diseases, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Hull M; Maple Leaf Medical Clinic, Toronto, Ontario, Canada.
  • Brumme Z; Department of Medicine, Division of Infectious Diseases, University of Toronto, Montreal, Ontario, Canada.
  • Brockman M; MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, Ontario, Canada.
  • Margolese S; Brisith Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Mandarino E; Brisith Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Angel JB; Brisith Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Routy JP; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
  • Anis AH; Brisith Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
  • Cooper C; Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada.
BMJ Open ; 11(12): e054208, 2021 12 16.
Article de En | MEDLINE | ID: mdl-34916326

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à VIH / COVID-19 Type d'étude: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Aspects: Ethics Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: BMJ Open Année: 2021 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à VIH / COVID-19 Type d'étude: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Aspects: Ethics Limites: Humans Pays/Région comme sujet: America do norte Langue: En Journal: BMJ Open Année: 2021 Type de document: Article Pays de publication: Royaume-Uni